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Eye developmentA subpopulation of cells expressesMyoDmRNAand the cell surface G8 antigen in the epiblast prior to the onset
of gastrulation. When an antibody to the G8 antigen was applied to the epiblast, labeled cells were later found
in the ocular primordia and muscle and non-muscle forming tissues of the eyes. In the lens, retina and
periocular mesenchyme, G8-positive cells synthesized MyoD mRNA and the bone morphogenetic protein
inhibitor Noggin. MyoD expressing cells were ablated in the epiblast by labeling them with the G8 MAb and
lysing them with complement. Their ablation in the epiblast resulted in eye defects, including anopthalmia,
micropthalmia, altered pigmentation and malformations of the lens and/or retina. The right eye was more
severely affected than the left eye. The asymmetry of the eye defects in ablated embryos correlated with
differences in the number of residual Noggin producing, MyoD-positive cells in ocular tissues. Exogenously
supplied Noggin compensated for the ablated epiblast cells. This study demonstrates that MyoD expressing
cells serve as a Noggin delivery system to regulate the morphogenesis of the lens and optic cup.
© 2009 Elsevier Inc. All rights reserved.Introduction
The epiblast gives rise to the three germ layers of the embryo
(Bellairs, 1986). Although cells from this primitive epithelium are
generally considered to be pluripotent, a small subpopulation within
this tissue of the chick embryo expresses mRNA for the skeletal
muscle speciﬁc transcription factor MyoD and a cell surface antigen
recognized by the G8monoclonal antibody (MAb) (George-Weinstein
et al., 1996; Gerhart et al., 2000, 2001, 2004a; Strony et al., 2005).
MyoD mRNA-positive (MyoD+) epiblast cells do not synthesize
detectable levels of MyoD protein or other skeletal muscle genes,
includingMyf5, Myogenin and sarcomeric myosin (George-Weinstein
et al., 1996; Gerhart et al., 2000, 2007).
The signiﬁcance of MyoD mRNA expression in the epiblast has
been explored in a series of in vitro and in vivo experiments. MyoD+
epiblast cells recruit multipotent epiblast cells to the skeletal muscle
lineage in culture by releasing an inhibitor of the bonemorphogenetic
protein (BMP) signaling pathway (Gerhart et al., 2004a). Although
MyoD+ epiblast cells will differentiate into skeletal muscle when
cultured under permissive conditions, in vivo, most appear to remain
undifferentiated even in the somites that give rise to the skeletal
muscles of the trunk and limbs (Gerhart et al., 2006, 2004a; Strony et
al., 2005). Their role in the somites is to promote the differentiation ofeorge-Weinstein).
ll rights reserved.myogenic progenitor cells by releasing the BMP inhibitor Noggin
(Gerhart et al., 2006). When MyoD+ epiblast cells are ablated in the
epiblast, organs become herniated through the ventral body wall of
older embryos due to a severe reduction in skeletal muscle (Gerhart et
al., 2006).
MyoD+ cells labeled with the G8 MAb also are integrated into
embryonic organs lacking skeletal muscle, including the heart and
brain (Gerhart et al., 2006, 2007). In these locations, they continue to
express MyoD mRNA and the G8 antigen and are not induced to form
cardiac muscle or neurons. The heart, brain and other organs of the
chick fetus also contain small numbers of MyoD mRNA+ cells
(Gerhart et al., 2001). In the adult mouse, MyoD protein was found
in myoid cells of the thymus and in myoﬁbroblasts derived from the
liver and kidney (Grounds et al., 1992; Mayer and Leinwand, 1997;
Redﬁeld et al., 1997). In addition, MyoD promoter and/or enhancer
element activity was detected outside of skeletal muscle in transgenic
mice (Asakura et al., 1995; Chen et al., 2005; Kablar, 2004; Kablar and
Rudnicki, 2002; Kirillova et al., 2007). With the exception of
myoﬁbroblasts that contain contractile proteins downstream of
MyoD (Walker et al., 2001), the signiﬁcance of small numbers of
MyoD+ cells in non-skeletal muscle tissues is unknown.
In a previous report that focused on the role of MyoD+ epiblast
cells in the somites, we noted that ablation of these cells in the
epiblast produces facial and eye malformations in addition to body
wall defects (Gerhart et al., 2006). In the following study, we
examined the role of MyoD+ epiblast cells during the formation of
non-muscle tissues of the eye. Eye development is regulated by a
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speciﬁcation of cells within the ocular primordia, morphogenesis and
cell differentiation (Gilbert, 2006). The optic vesicle evaginates from
the anterior/lateral neural plate as the adjacent ectoderm thickens to
form the lens placode. Soon thereafter, the optic vesicle invaginates to
form the optic cup and its derivatives, the retina and retinal
pigmented epithelium (RPE), while the lens vesicle develops from
the invaginating lens placode. The anterior margin of the optic cup
gives rise to the iris and ciliary body and contributes progenitor cells
to the retina (Gould et al., 2004). Cells fated to differentiate into the
extraocular muscles emerge within the prechordal mesoderm and
unsegmented paraxial mesoderm before populating the periocular
mesenchyme (Couly et al., 1992; Gage et al., 2005; Jacob et al., 1984;
Johnston et al., 1979; Noden, 1983).
Several families of secreted molecules, including BMPs, are
involved in the orchestration of eye development. BMPs-2, -4, -5, -6
and -7 and BMP receptors BMPR-IA, -IB and -II have been mapped to
the embryonic eye (Beebe et al., 2004; Belecky-Adams and Adler,
2001; Wordinger and Clark, 2007). Deﬁning the processes regulated
by the BMP signaling pathway during eye development has been
achieved through genetic knockout and knockdown strategies and by
over-expressing Noggin. These approaches revealed that BMP
signaling is required for the formation of the lens, retina, RPE, ciliary
body and cornea by mediating communication between tissues and
regulating cell proliferation, apoptosis and differentiation (Beebe,
1986; Belecky-Adams and Adler, 2001; Belecky-Adams et al., 2002;
Chang et al., 2001; Donner et al., 2006; Dudley et al., 1995; Faber et al.,
2001, 2002; Furuta and Hogan, 1998; Hung et al., 2002; Jena et al.,
1997; Litsiou et al., 2005; Luo et al., 1995; Rinaudo and Zelenka, 1992;
Saika et al., 2001; Sanford et al., 1997; Trousse et al., 2001; Wawersik
et al., 1999; Wordinger and Clark, 2007; Zhao et al., 2002).
While loss of function mutations in BMP-4 and overproduction of
Noggin cause varying degrees of dysgenesis of ocular tissues (Belecky-
Adams et al., 2002; Trousse et al., 2001; Zhao et al., 2002),
overexpression of BMPs and null mutations in Noggin and Chordin
also result in eye defects (Bachiller et al., 2000; McMahon et al., 1998;
Ogita et al., 2001). The BMP inhibitors Noggin, Follistatin and Chordin
shift the fate of ectoderm cells from the epidermal lineage to
neuroectoderm and direct the formation of anterior neural structures
that give rise to the optic vesicle (Zilinski et al., 2004). These three
BMP inhibitors, along with Ventroptin, Gremlin and Dan, have been
mapped to the developing eye (Belecky-Adams and Adler, 2001; Ogita
et al., 2001; Sakuta et al., 2001; Trousse et al., 2001; Zhao et al., 2002).
Inhibition of the BMP signaling pathway also is required for the
differentiation of the extraocular muscles (Tzahor et al., 2003; von
Scheven et al., 2006). These studies illustrate the importance of
modulating BMP signaling both temporally and spatially for eye
development to proceed normally.
One source of BMP inhibitors in the developing eye is the neural
crest (Tzahor et al., 2003). Neural crest cells release Noggin and
Gremlin in the periocular mesenchyme; however, extraocular muscle
differentiation occurs in their absence (Diehl et al., 2006; Evans and
Gage, 2005; Olsson et al., 2001; Tzahor et al., 2003), indicating that an
additional population of cells must serve as a source of BMP inhibitors
in the periocularmesenchyme. Neural crest cells also populate the iris,
ciliary body, cornea, trabecular meshwork and primary vitreous but
they have not been detected in the lens or optic cup (Cvekl and Tamm,
2004; Gage et al., 2005; Ittner et al., 2005; Johnston et al., 1979; Le
Lievre and Le Douarin, 1975).
The following experiments were designed to map the integration
sites of MyoD+ cells during the formation of the embryonic eye,
determine whether they express Noggin in different ocular tissues
and characterize the eye defects that arise as a result of their ablation
in the epiblast. This study demonstrates that MyoD+ cells are the
major source of Noggin in non-muscle forming tissues of the eye and
are required for the normal morphogenesis of the lens and optic cup.Materials and methods
Tracking MyoD+ epiblast cells in the embryo
White Leghorn chick embryos (BE Eggs) were removed from the
shell and staged according to the method of Hamburger and Hamilton
(1951). Analyses of the positions of MyoD+ epiblast cells for the ﬁrst
48 h after laying were accomplished by removing stage 2 embryos
from the yolk, rinsing in Dulbecco's phosphate buffered saline (PBS)
(Invitrogen), positioning the embryo on a raft in awell containing thin
albumen (the less viscous portion of the egg white that is almost
completely lacking in ovomucin), and labeling the cells with the G8
MAb and a goat anti-mouse IgM Mu chain secondary antibody
conjugated with either ﬂuorescein, Alexa 488 or rhodamine (Chemi-
con, Jackson Labs) (Gerhart et al., 2007). Following rinsing, labeled
embryos were incubated at 37 °C with 4.5% CO2 in air. Since embryos
survive for only 48 h in this culture system, the distribution of stage 2
MyoD+ epiblast cells during later stages of eye development was
determined by placing the contents of the egg in a dish, labeling with
the G8 MAb and a ﬂuorescent secondary antibody while the embryo
resided on the yolk, returning the embryo to the shell and incubating
at 37 °C in an egg incubator for 3–5 days (Gerhart et al., 2006, 2008).
This ex-ovo/in-ovo whole embryo culture system supports develop-
ment into the late fetal period (Gerhart et al., 2008).
Stage 2 embryos pre-labeled with G8 and secondary antibodies
were incubated to reach stages 3–7 and ﬁxed in 2% formaldehyde for
20–60 min. Nuclei were labeled with Hoechst dye (Sigma-Aldrich).
Pre-labeled embryos grown to stages 17–25 were ﬁxed overnight in
4% formaldehyde and embedded in parafﬁn. Transverse sections (10
μm) were counterstained with Hoechst dye and mounted in Elvanol
(Dupont). Fluorescent cells were visualized with a Nikon Eclipse 800
epiﬂuorescence microscope (Optical Apparatus) equipped with the
following ﬁlters: excitation 530–560, barrier 573–648 for Cy3 and
rhodamine; excitation 465–495, barrier 515–555 for Alexa 488;
excitation 330–380, barrier 435–485 for Hoechst dye. Photographs
were taken under 4× NA 0.2, 40× oil NA and 60× oil NA 1.4 objectives.
Images were produced with the Evolution QE Optronics video camera
(Media Cybernetics) and the Image Pro Plus image analysis software
program (Phase 3 Imaging Systems). Figures were annotated and
adjusted for brightness and contrast using Adobe Photoshop 6.0.
Immunoﬂuorescence localization and in situ hybridization
Double labeling for the G8 antigen and MyoD or Noggin mRNA, or
MyoD mRNA and Noggin protein was carried out as described
previously (Gerhart et al., 2000, 2004b). The primary antibodies
were applied ﬁrst and tagged with either ﬂuorescein conjugated goat
anti-mouse IgM Mu chain or donkey anti-goat IgG (Chemicon). The
goat polyclonal antibody to Noggin was obtained from R&D Systems.
After staining with primary and ﬂuorescent secondary antibodies,
sections were incubated in Cy3 labeled 3DNA™ dendrimers (Geni-
sphere, Inc.) conjugated with an antisense cDNA sequence for chicken
MyoD mRNA (5′-TTCTCAAGAGCAAATACTCACCATTTGGTGATTCCG
TGTAGTA-3′ (Dechesne et al., 1994) (L34006) or chicken Noggin
(5′-TCTCGTTAAGATCCTTCTCCTTGGGGTCAAA-3′) (Tonegawa and
Takahashi, 1998) (NM_204123). Nuclei were counterstained with
Hoechst dye. Sections were mounted in Gelmount (Electron Micros-
copy Sciences).
Ablating MyoD+ epiblast cells in the epiblast
Determination of the effects of ablating MyoD+ epiblast cells on
eye development was carried out by placing stage 2 embryos in a
tissue culture dish, incubating the embryowith the G8MAb and lysing
labeled cells with baby rabbit complement (Cedar Lane, Inc.) while
they resided on the yolk (Gerhart et al., 2006, 2008). Control embryos
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only, or the E12 MAb and complement. The E12 MAb binds to a
separate subpopulation of epiblast cells that expresses the neurogenic
transcription factor NeuroM (Strony et al., 2005). Cell lysis was
visualized by incubating embryos in trypan blue (Gerhart et al., 2006).
Embryos were returned to a host shell and incubated at 37 °C for 3–6
days. The following numbers of control and treated embryos were
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agarose beads (BioRad) soaked in a solution of 100 ng of human
recombinant Noggin (PeproTech) per ml of PBS were inserted on the
right side of the embryo lateral to the most cranial somite, the third
and fourth somites, and the most caudal three somites (Fig. 6A)
(Gerhart et al., 2006). Control embryos received beads soaked in PBS
alone. Embryos were placed in 60 ml capacity glass bowls (Dollar
Tree), covered and cultured at 37 °C for 2–4 days.age 5 and 7 embryos. Whole stage 2 embryos were double labeled with the G8 MAb and
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and incubated until they reached stages 5 (C–F) or 7 (G–N). Stage 7 embryos were
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E and F). By stage 7, G8+ cells were found in the prechordal mesoderm (H), the anterior
/lateral neural plate (M and N). Scale bars, 135 μm (C and G) and 9 μm (D–F and H–N).
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Cells that are labeled with the G8 MAb are incorporated into the
developing eye
MyoD+ epiblast cells were identiﬁed in the stage 2 epiblast based
on their expression of the G8 antigen and MyoD mRNA (Fig. 1B)
(Gerhart et al., 2006). Living stage 2 embryos were ﬂuorescently
labeled with the G8 MAb in order to track the sites of incorporation of
MyoD+ cells during eye development. In a previous study we
determined that cells labeled with the G8 MAb applied to the stage 2
epiblastwere integrated into the developing somites, heart and central
nervous system (Gerhart et al., 2006, 2007, 2008). Epiblast cells that
expressed the G8 antigen within 3 h after the embryo was incubated
with the G8 MAb were not tagged by residual unbound antibodies or
the transfer of antibodies from other cells (Gerhart et al., 2006).
All MyoD+ epiblast cells were present in the posterior/marginal
region of the stage 2 epiblast (Figs. 1A and B). Approximately 24
h after applying the G8 MAb and ﬂuorescent secondary antibodies
(stage 5–5+), ﬂuorescent cells were observed along the posterior
margin of the epiblast, within the primitive streak (not shown), lateral
to the streak and in the head process, a mesodermal structure that
forms the notochord (Figs. 1D–F). By stage 7, ﬂuorescent cells were
observed in the unsegmented paraxial mesoderm (not shown) and
prechordal mesoderm (Fig. 1H), the tissues of origin of the extraocular
muscles (Couly et al., 1992; Gage et al., 2005; Jacob et al., 1984;
Johnston et al., 1979; Noden, 1983). G8 labeled cells also were found
in the region of the ectoderm containing the primordia of the sensory
placodes (Litsiou et al., 2005), including the lens placode (Figs. 1I–L),
and in the anterior/lateral neural plate from which the optic vesicle
evaginates (Chow and Lang, 2001) (Figs. 1M and N). The movements
of G8 labeled cells from the posterior epiblast suggest that some
MyoD+ epiblast cells enter the mesodermwhile others remain in the
ectoderm.
By stage 17, MyoD+ cells tagged with the G8 MAb were found as
single cells or in foci of approximately two to eight cells within the
eyes (Fig. 2). G8 labeled cells (G8+) constituted a minor subpopu-
lation in the eye, and therefore, not all sections contained these cells inFig. 2. Distribution of G8+ cells in the eyes of stage 17 and 18 embryos. Stage 2 embryos w
secondary antibody, incubated to stages 17 or 18, ﬁxed and sectioned. Nuclei were counter
shown in panel A. The areas indicated by the letters in panel A are shown at high magniﬁcat
region (PF) of the lens (arrows in panel B) and the anterior margin of the optic cup (arrowh
posterior optic cup (D) and periocular mesenchyme (E and F). Scale bars, 27 μm (A) and 1the same locations (Figs. 2 and 3). In the lens vesicle, G8+ cells were
present in the equatorial zone where lens epithelial cells initiate
differentiation, as well as in the anterior epithelium and posterior
primary lens ﬁber region (Fig. 2B). The optic cup contained foci of
G8+ cells in its anterior margin (Fig. 2C) and within the posterior
region of the developing neural retina (Fig. 2D). The G8 expressing
cells in the chick retina may be related to the rare population of retina
cells that weakly express GFP under the regulation of enhancer and
promoter elements of the MyoD gene (Kirillova et al., 2007). Cells
labeled with the G8 MAb also were present within the periocular
mesenchyme surrounding the lateral and posterior regions of the
optic cup (Fig. 2E and F). The results of these experiments
demonstrate that cells labeled with the G8 MAb are incorporated
into skeletal muscle (periocular mesenchyme) and non-skeletal
muscle forming tissues (lens and optic cup) during eye development.
G8+ cells express MyoD mRNA and Noggin in the developing eye
Cells labeledwith the G8MAbwere examined for the expression of
MyoD mRNA and Noggin mRNA and protein in representative
sections through the eyes of three stage 17–18 and three stage 23–
24 embryos (Table 1). All G8+ cells expressed MyoDmRNA. At stages
23–24, Noggin mRNA was found in all G8+ cells in the eyes and only
7% of the cells expressing Noggin lacked detectable levels of G8.
Greater than 80% of the cells that expressedMyoDmRNAwere stained
with an antibody to Noggin protein. Two thirds of the cells with
Noggin mRNA or protein contained G8 or MyoD mRNA.
The distribution of double and single labeled cells is shown in
Fig. 3. G8+/MyoD mRNA+ cells (Figs. 3E–H), G8+/Noggin mRNA+
cells (Figs. 3I–L), MyoD mRNA+/Noggin protein+ cells (Figs. 3M–P)
and Noggin protein+/MyoD mRNA− cells (Figs. 3C and D) were
found in the lens, anterior margin and posterior derivatives of the
optic cup, and periocular mesenchyme of stage 17–18 and 23–24
embryos. A few Noggin mRNA+/G8− cells (Fig. 3J) and Noggin
protein+/MyoD mRNA− cells were present in the lens and optic
cup derivatives (Figs. 3C and D). These double labeling experiments
demonstrate that G8+/MyoD+ cells are the major source of
Noggin in ocular tissues.ere labeled with the G8 MAb and a rhodamine (red) or ﬂuorescein (green) conjugated
stained with Hoechst dye (blue). A representative section through the stage 17 eye is
ion in panels B–F. G8+ cells were present in the equatorial zone (EZ) and primary ﬁber
ead in panel B, arrow in panel C). G8+ cells also were present in the retinal layer of the
3 μm (B–F).
Fig. 3. Co-expression of G8, MyoDmRNA and Noggin in the developing eye. The eyes of stage 18 (A, C, E, G, H, M and O) and stage 24 (B, D, F, I, J, K, L, N and P) embryos were sectioned
and stained with H&E (A and B) or double labeled with the G8 MAb (G8 A) (green) and dendrimers to MyoDmRNA (MyoDm) (red) or Noggin mRNA (Nog m) (red), or an antibody
to Noggin protein (Nog P) (green) and dendrimers to MyoD mRNA. Nuclei were counterstained with Hoechst dye (blue). The overlap of red and green appears yellow-white in
merged images. Cells co-expressing G8 and MyoD mRNA were present in the lens (LNS) (E), anterior optic cup (AOC) (F), the retinal layer of the posterior optic cup (POC) (G) and
periocular mesenchyme (POM) (H). Cells expressing the G8 antigen also expressed Noggin mRNA in the lens (I), anterior and posterior optic cup (J and K), and periocular
mesenchyme (L). A few cells with Noggin mRNA were not stained with G8 in the adjacent lens. Noggin protein and MyoD mRNA were co-localized in some cells of the lens (M),
anterior optic cup (arrow in N), posterior optic cup (O) and periocular mesenchyme (P). Other cells labeled for Noggin protein did not contain detectable levels of MyoD mRNA
(MyoD m-) in the lens and optic cup (arrows in C and D). Scale bars, 56 μm (A and B) and 13 μm (C–P).
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MyoD+ cells were ablated in the epiblast by lysing G8 labeled cells
with complement (Gerhart et al., 2006, 2008). Consistent with our
previous experiments (Gerhart et al., 2006), the stage 2 epiblast
contained 67±3 G8+ cells (n=6 embryos). All G8+ cells were
located in the posterior/medial region of the epiblast. Cell lysis was
demonstrated by incubation in trypan blue (Fig. 4B). Embryos treated
with G8 and complement contained 66±2 lysed cells (n=4),Table 1
Expression of the G8 antigen, MyoD mRNA and Noggin in the developing eye.
Stages 17–18
# of cells
G8+ cells with MyoD mRNA 120/120
MyoD mRNA+ cells without G8 1/121
G8+ cells with Noggin mRNA 39/40
Noggin mRNA+ cells without G8 16/55
MyoD mRNA+ cells with Noggin protein 71/76
Noggin protein+ cells without MyoD mRNA 5/76
Tissue sections through three stage 17–18 and three stage 23–24 eyes were double labeled
dendrimers and antibodies to Noggin protein. # of cells=the number of cells with or witho
were derived by pooling the cell counts from representative sections from three embryos st
number of cells labeled for the ﬁrst marker×100. All G8+ cells expressed MyoD mRNA. On
mRNA or protein lacked detectable levels of G8 or MyoD mRNA, respectively.whereas only 1 lysed cell was observed in two embryos treated
with complement alone.
To determine whether more cells emerged in the epiblast after
ablation, a secondary antibody conjugated with ﬂuorescein was
applied to the embryo directly after washing out the complement to
label cells that had bound the G8MAb. Three hours later, the embryos
were restained with another application of the G8 MAb and a
secondary antibody conjugated with rhodamine. Cells tagged with
ﬂuorescein only or both ﬂuorochromes corresponded to the originalStages 23–24







with the G8 MAb and either dendrimers to MyoD mRNA or Noggin mRNA, or MyoD
ut both labels over the total number of cells labeled for the ﬁrst marker. These numbers
ained with the same probes. %=the number of cells with or without both labels÷total
ly one cell with G8 lacked detectable levels of Noggin mRNA. Some cells with Noggin
Fig. 4. Lysis of MyoD+ cells in the epiblast and its effects on eye morphogenesis. MyoD+ cells in the stage 2 epiblast were labeled with the G8 MAb and lysed with complement. The
area in the box in the drawing of the stage 2 embryo in panel A is shown in panel B. The letters correspond to the areas shown at higher magniﬁcation in panels C and D. The uptake of
trypan blue reveals the presence of lysed cells (B). A ﬂuorescein conjugated secondary antibody was applied following treatment with complement (green). After incubating the
embryos for 3 h, the G8 MAb was reapplied and tagged with a secondary antibody conjugated with rhodamine (red). The overlap of red and green appears yellow-white in merged
images. Most labeled cells were tagged with both ﬂuorochromes (arrows in panel C). Nuclei appeared fragmented (arrowhead in panel C). Cells that expressed the G8 antigen within
3 h after ablation were labeled with only rhodamine (D). These cells were concentrated on the left side of the epiblast a ﬁeld away from the cells shown in panel C. The right (E) and
left eyes were normal in control embryos treated with the E12 MAb and complement. One ablated embryo had an absence of visible eye tissue on the right (black arrow) and a
normal eye on the left (red arrow) (F). Other embryos exhibited micropthalmia (G) or a lack of pigmentation (H). Scale bars, 56 μm (B) and 9 μm (C and D).
35J. Gerhart et al. / Developmental Biology 336 (2009) 30–41population of G8 labeled cells lysed with complement in the stage 2
epiblast, whereas cells stainedwith rhodamine only had expressed G8
after the initial labeling period (Fig. 4C). Therewere 11±3 cells (n=5
embryos) that were stained with rhodamine only and, therefore, had
emerged in the epiblast after the ablation procedure (Fig. 4D). In four
out of ﬁve embryos, 64–100% of these newly labeled cells were
present on the left side of the embryo in a ﬁeld adjacent to the lysed
cells. This experiment demonstrates that additional cells express the
G8 antigen after lysis of the original population, and in the majority of
these embryos, the newly emerging G8 expressing cells were present
on the left side of the posterior epiblast. These results suggest that
subtle differences in the timing of ablation (early to late stage 2) could
lead to phenotypes of varying severity.
Ablation of G8+/MyoD+ cells in the epiblast adversely affects eye
development
On the third day after ablating MyoD+ cells in the epiblast, the
eyes appeared normal externally. Examination of the complete set of
serial tissue sections from two of these embryos revealed that the left
eyes had a normal morphology while the lens vesicles of both of the
right eyes were more densely stained than the control lenses and
lacked a lumen (Fig. 5A and B). By the ﬁfth day after ablation, all of the
right eyes and 27% of the left eyes had externally visible eye defects,
including clinical anopthalmia, micropthalmia, an abnormal shape
and/or altered pigmentation (Tables 2 and 3; Figs. 4F–H). The right
eyes were more severely affected than the left eyes (Tables 2 and 3).
The asymmetry in the severity of the defects may reﬂect the
emergence of additional G8+ cells on the left side of epiblast after
the ablation procedure.
None of the eyes in control embryos treated with buffer, the G8
MAb or complement alone, or the E12 MAb and complement had
visible eye defects (Table 2; Fig. 4E). The E12MAb binds speciﬁcally to
a subpopulation of epiblast cells that expresses the NeuroM
transcription factor, but not MyoD or G8 (Gerhart et al., 2006; Strony
et al., 2005). Ablation of the E12+ and G8+ subpopulations ofepiblast cells results in different malformations, thereby demonstrat-
ing the speciﬁcity of the ablation procedure (Gerhart et al., 2006).
Histological analyses of the ablated embryos revealed eye defects
of varying severity (Tables 2 and 3; Fig. 5). All of the right eyes and
64% of the left eyes were abnormal. Half of the left eyes that appeared
normal externally had internally visible defects. A frequently
observed malformation was folding of the neural retina within the
vitreous body (Table 3; Figs. 5E and I). In some embryos, retinal
folding occurred in right and left orbits of normal size, suggesting that
the retinal tissue had undergone abnormal expansion. Retinal folds
were present in eyes with either a normal lens (Fig. 5E), or more
commonly, eyes with lens defects (Table 3). The lens malformations
included alterations in size (enlarged or reduced) or an absence of
identiﬁable lens tissue (Table 3).
One of the ablated embryos contained a normal lens accompanied
by retinal folds in the left eye (embryo #8, Table 3). The lens and optic
cup in the right eye of this embryo were small and malformed and
appeared to be arrested in development. Pigment was present
throughout the optic cup (Figs. 5H and J; Table 3 embryo #8).
Another embryo with retinal folds and no lens in the left eye lacked
internally visible ocular tissue on the right (Fig. 5G; Table 3, embryo
#10). The RPE had either a normal morphology or contained folds that
were less pronounced than those of the neural retina (Figs. 5K and L).
The embryo with the most severe phenotype had only a small, dense
piece of pigmented tissue on both sides of the head (Fig. 5D; Table 3,
embryo #11). The conclusion from these experiments is that ablation
of MyoD+ cells in the stage 2 epiblast disrupts the morphogenesis of
the lens and/or optic cup derivatives. While both eyes are affected by
the loss of MyoD+ epiblast cells, the defects in the right eye are more
severe than those in the left eye.
Noggin producing MyoD+ cells are reduced in the eyes of ablated
embryos
Determination of whether the severity of eye defects correlated
with the numbers of residual MyoD+ cells was carried out by
Fig. 5. Histological appearance of the eye defects that arise after ablating MyoD+ cells in the epiblast. Stage 2 embryos were treated with the G8 MAb and complement to ablate
MyoD+ cells in the epiblast. Embryos were incubated to stage 17 (A and B) or stage 23 (C–L). Sections were stained with H&E (A–E and G–I), the G8 MAb tagged with ﬂuorescein
(green) and Hoechst nuclear dye (blue) (F), or Hoechst nuclear dye only (J–L). The eyes of control embryos treated with complement alone are shown in panels A and C. Unlike the
control lens vesicle of a stage 17 embryo (A), the right lens did not contain a lumen (B). A vesicle was present in later sections through the left eye (not shown). One of the left eyes
lacked morphologically distinct ocular tissues (D) (embryo #11, Table 3). Another left eye exhibited a normal lens with folds of retinal tissue (E) (embryo #8, Table 3). Residual
MyoD+ cells stained with the G8 MAb were present in the lens of the left eye of an ablated embryo (F) (embryo #2, Tables 3 and 4). The right eye was either missing identiﬁable
ocular tissues (G) (embryo #10, Table 3) or contained a small lens and distorted optic cup (H) (embryo #8, Table 3) or folds of retinal tissue (I) (embryo #7, Table 3). Pigment was
present throughout the optic cup of the eye shown in panel H (J). The RPE was present and pigmented in the right (K) and left (L) eyes containing retinal folds. Scale bars, 135 μm (A
and B), 56 μm (C–E and G–I), 27 μm (J–L) and 13 μm (F).
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section through the eyes of stage 23–24 control (unablated) and
ablated embryos (Table 4). All three control embryos contained
fewer MyoD+ cells in the right lens than the left lens. Although
the right lenses were smaller than the left lenses in two embryos
(#1 and #3: number of sections containing lens tissue: right 30
and 28, left 55 and 36), both lenses were similar in size in the
third embryo (#2: right 26, left 27). Two of the control embryos
(#2 and #3) contained fewer MyoD+ cells in the right than theleft neural retina and periocular mesenchyme. Differences in the
numbers of MyoD+ cells in the right and left eyes did not
correlate with the differences in the overall size of the eyes in
control embryos, as one of the right eyes was larger than the left
eye (embryo #2), another was smaller on the right (embryo #1),
and the third pair of eyes was similar in size (embryo #3).
Therefore, differences in the number of MyoD+ cells in the two
eyes do not consistently correlate with the size of the tissue in
which they were located.
Table 4
Distribution of MyoD+/G8+ cells in control and ablated eyes.
Retina Lens POM
Left Right Left Right Left Right
St. 23-24: Control
#1 48 52 45 6 20 20
#2 55 28 30 10 27 11
#3 87 49 54 11 39 33
St. 23-24: Ablated
#2, Table 3 5 0 10 0 0 1
#7, Table 3 5 0 0 0 1 0
#9, Table 3 14 4 2 1 0 0
All sections through the eyes of three stage 23–24 control embryos and three embryos
in which MyoD+ cells were ablated in the epiblast were labeled with the G8 MAb and/
or dendrimers to MyoD mRNA. The number of G8 and/or MyoD mRNA-positive cells
was determined in the retina, lens and periocular mesenchyme (POM). In control
embryos, the left lens consistently contained more MyoD+ cells than the right lens.
Two out of three control embryos contained fewer cells in the right than left neural
retina. The numbers assigned to the ablated embryos correspond to the numbers of the
embryos described in Table 3. Ablation of MyoD+ cells in the epiblast reduced or
eliminated MyoD+ cells in ocular tissues. Fewer MyoD+ cells were present in the right
eyes of ablated embryos than the left eyes.
Table 2












CT 22 22 0 0
Ablated 11 0 8 3
Ablated + Noggin 5 5 0 0
Internal morphology
CT 6 6 0 0
Ablated 11 0 4 7
Ablated + Noggin 4 3 0 1
MyoD+ cells were ablated in the stage 2 epiblast by labeling with the G8 MAb and
lysing with complement (Ablated). Control embryos (CT) were incubated in buffer, G8
or complement only, or the E12 MAb and complement. Beads soaked in Noggin were
implanted into the stage 10 embryo of some ablated embryos (Ablated + Noggin).
Embryos were incubated to stages 23–26 (days 4–5). The morphology of the eyes was
observed on the external surface of the embryo and in tissue sections (internal
morphology). Eye defects were more common in the right eye than the left eye.
Exogenous Noggin compensated for the ablated MyoD+ epiblast cells.
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tissues of ablated embryos compared to control embryos (Tables 4
and 5). One ablated embryo contained residual MyoD+/G8+ cells in
the lens and retina (embryo #2, Table 4). Both of these tissues
appeared to have a normal morphology (Table 3). MyoD+/G8+ cells
were not found in the periocular mesenchyme of this eye, suggesting
that sufﬁcient numbers of these cells were present in the lens and
retina to support their morphogenesis independently of the
mesenchyme.
Although the second embryo had the same number of residual
G8+/MyoD+ cells in the retina of the left eye as the ﬁrst ablated
embryo, its retina had a folded appearance (embryo #7, Tables 3 and
4). Only two G8+/MyoD+ cells remained in the lens of this eye. The
left eye of the third embryo also contained retinal folds even though
the folds containedmoreMyoD+/G8+ cells than the retina of the eye
that lacked folds (embryos #9 and #2). The lens of this eye had only
twoMyoD+/G8+ cells but appeared to have a normal morphology. It
is therefore possible that a critical number of residual MyoD+/G8+
cells in either the retina or the lens may compensate to some degree
for their loss in the adjacent tissue.
The right eyes of ablatedembryos contained fewer residualMyoD+/
G8+cells than the left eyes (Table 4).WhereasMyoD+/G8+cellswere
present in the left eyes of all three embryos, these cells were notTable 3





3 Normal Uneven pigment
4 Normal Anopthalmia
5 Normal Misshapen
6 Normal No pigment
7 Normal No pigment
8 Normal Anopthalmia
9 Uneven pigment Decreased pigment
10 Micropthalmia Micropthalmia
11 Micropthalmia Micropthalmia
MyoD+ cells were ablated in the stage 2 epiblast by labeling with the G8 MAb and lysing w
was observed on the external surface of the embryo and in tissue sections (internal morp
morphology on the external surface indicates that the eye was not round. Other malformatio
spot of pigmentation or no pigment), misshapen retina (not cup shaped but there were no fo
and thickened in the anterior to posterior dimension), missing lenses and anopthalmia (abdetected in the lens or retina of two of the right eyes of ablated embryos
(#2 and#7, Table 4). One of these eyes lacked detectable lens tissue and
the other had a misshapen lens (Table 3). A few MyoD+/G8+ cells
were found in the right retina and lens of the third embryo (#9).
This eye also had a misshapen lens. All of the right eyes exhibited
retinal folding. These results demonstrate that the asymmetry in the
severity of the eye defects correlates with a greater reduction in the
number of residual MyoD+/G8+ cells in the right eye than the
left eye.
The results displayed in Table 1 demonstrate that MyoD+/G8+
cells are the primary source of Noggin in stage 23–24 eyes. The eyes of
ablated embryos were examined for Noggin expression to determine
whether other cells compensated for the loss of Noggin producing
MyoD+/G8+ cells (Table 5). Six Noggin+ cells were observed in the
left eye of embryo #7 and half of these cells expressedMyoD. Only one
Noggin+ cell was present in the right eye of this embryo. This cell
lacked detectable levels of MyoD mRNA. The second embryo
contained 17 Noggin+ cells. Most of these cells were present in the
retina and all but one Noggin+ cell was stained for G8. Five Noggin+/
G8+ cells were detected in the right eye of this embryo. This analysis
revealed that ablation of MyoD+ cells in the epiblast results in a
reduction in Noggin producing cells in the eye. Comparison of the
phenotype of the ablated eyes with the number of residual Noggin
producing MyoD+ cells indicates that the severity of ocularInternal morphology
Left Right
Normal Misshapen retina
Normal Retinal folds/no lens
Normal Large lens
Normal Anopthalmia
Retinal folds/misshapen lens Misshapen retina/misshapen lens
Misshapen retina Small retina/no lens
Slight retinal folds/misshapen lens Retinal folds/
misshapen lens
Retinal folds Misshapen retina and lens
Retinal folds/uneven pigment Retinal folds/misshapen lens
Retinal folds/no lens Pigmented tissue only
Pigmented tissue only Pigmented tissue only
ith complement. Embryos were incubated to stages 23–26. The morphology of the eyes
hology). Eye defects were more severe in the right eye than the left eye. Misshapen
ns include micropthalmia (small eye), altered pigmentation (uneven, decreased, small
lds in the tissue), folds of neural retina tissue, misshapen lenses (small, densely stained
sence of morphologically identiﬁable ocular tissues).
Table 5
Distribution of Noggin+ cells in the eyes of ablated embryos.
Embryo Retina Lens POM
Left Right Left Right Left Right
#7 3 Nog+/MyoD+ 0 Nog+ 0 Nog+ 0 Nog+ 0 Nog+
3 Nog+/MyoD− 1 Nog+/MyoD−
#9 14 Nog+/G8+ 4 Nog+/G8+ 2 Nog+/G8+ 1 Nog+/G8+ 0 Nog+ 0 Nog+
1 Nog+/G8−
All sections through the stage 23–24 eyes of embryos ablated at stage 2 were double labeled for the G8 antigen or MyoDmRNA and Noggin mRNA or Noggin protein. The number of
cells expressing Noggin (Nog)with or withoutMyoD or G8was determined in the retina, lens and periocular mesenchyme (POM). Ablation ofMyoD+ cells in the epiblast reduced or
eliminated Noggin+ cells in ocular tissues. Fewer Noggin+ cells were present in the right eyes of ablated embryos than the left eyes.
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Noggin.
Exogenous Noggin compensates for the ablated MyoD+ cells
Determination of whether exogenous Noggin could compensate
for the missing MyoD+ cells was carried out by implanting beads
soaked in Noggin into stage 10–13 ablated embryos after the lens
placode and optic vesicle were speciﬁed within the ectoderm and
neuroectoderm, respectively. The most cranial implantation site was
adjacent to the ﬁrst somite on the right side of the embryo (Fig. 6A).Fig. 6. Effects of exogenous Noggin on eye development in embryos treated to ablate MyoD+
were incubated to stages 10–13. Afﬁgel blue beads soaked in PBS or human recombinant No
adjacent to the ﬁrst somite caudal to the developing eye. The arrow in panel A indicates the p
embryos implanted with PBS beads continued to exhibit eye defects (B and C). The left (D a
beads appeared normal. Scale bar, 56 μm (C, E and G).This implantation site was expected to limit the amount of Noggin
that diffused to the eye, thereby reducing the likelihood that eye
defects would result from excessive blockage of BMP signaling, as
occurs when Noggin is over-expressed in the eye (Huillard et al.,
2005; Zhao et al., 2002). The beads eventually dislodged from the
tissue but were secured in the vicinity of the implantation site by the
embryonic membranes. As the embryo developed, the ﬁrst bead was
present in the cervical ﬂexure adjacent to the eye (Fig. 6F).
Whereas the eyes of ablated embryos implanted with beads
soaked in buffer continued to exhibit the same defects as ablated
embryos lacking beads (Figs. 6B and C), the external morphology ofcells in the epiblast. MyoD+ cells were ablated in the stage 2 epiblast and the embryos
ggin were implanted on the right side of the embryo (A). The most proximal bead was
osition of the eye. Stage 23–24 embryos were sectioned and stained with H&E. Ablated
nd E) and right (F and G) eyes of most ablated embryos implanted with Noggin soaked
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after supplementation with exogenous Noggin (Table 2; Figs. 6D and
F). Histological analyses revealed that the right and left eyes of three
out of four ablated embryos that received Noggin soaked beads
appeared normal (Table 2; Figs. 6E and G). The ability of exogenous
Noggin to restore normal eye development after ablation in the
majority of embryos, combined with the results of the previous
experiment inwhich itwas found thatNogginproducingMyoD+/G8+
cells were reduced or absent in ocular tissues of ablated embryos,
suggests that MyoD expressing cells are a critical source of Noggin
during eye development.
Discussion
Cells that express MyoD mRNA and the G8 antigen emerge in the
epiblast prior to the establishment of the three germ layers (Gerhart
et al., 2000). We have used the G8 MAb to tag these cells in the
epiblast and track their sites of integration as development progressed
(Gerhart et al., 2006, 2007; present study). The strength of this
approach is the speciﬁcity of the G8 MAb for cells that express MyoD
(Gerhart et al., 2004a; Strony et al., 2005). However, there are
limitations to using antibodies as lineage tracers, including the
possibilities that unbound antibody may not be completely removed
with rinsing and/or the antibody may be transferred between cells.
The following evidence supports the conclusion that the majority of
the G8 labeled cells that we detected in ocular tissues were derived
from those cells that bound the G8 MAb in the epiblast. First, there
was insufﬁcient G8 MAb remaining in the embryo to stain epiblast
cells that initiated the expression of the G8 antigen during the 3-
h period following the completion of the labeling and ablation
procedures (Gerhart et al., 2006 and present study). These newly
emerging G8+ cells are only detected by reapplying the G8 MAb.
Second, ablating cells that bound the G8 MAb in the epiblast severely
reduced the number of G8+/MyoD+ cells in the eyes. Third, all cells
that were labeledwith the G8MAb in the eyes of stage 23–24 embryos
expressed MyoD and Noggin, suggesting that the G8 MAb was not
transferred to paraxial myoblasts that do not appear to synthesize
Noggin (Gerhart et al., 2006) or leukocytes that do not express MyoD.
These results combined suggest that MyoD+/G8+/Noggin+ cells
present in the eyes of chick embryos originate from cells that express
MyoD mRNA and the G8 antigen in the epiblast. Conﬁrmation of a
lineage relationship between MyoD+ cells of the epiblast and the
eyes awaits the development of an epiblast-speciﬁc MyoD reporter
mouse.
Cells that express MyoD mRNA and the G8 antigen in the epiblast
and in a variety of tissues in older embryos are not induced to
differentiate into non-skeletal muscle cell types (Gerhart et al., 2001,
2007). Stable programming ofMyoD+cells in the epiblastmay ensure
that they are capable of releasing Noggin to titrate the activities of
BMPs in diverse environments. MyoD mRNA is not translated into
detectable levels of protein in epiblast cells (Gerhart et al., 2006, 2007),
and unlike embryos in which MyoD+ cells are ablated in the epiblast,
development proceeds normally in the MyoD knockout mouse
(Rudnicki et al., 1992). Therefore, expression of MyoD mRNA appears
to be a read out for, but not a regulator of,MyoD+epiblast cell function
as a Noggin delivery system.
The importance of MyoD+ cells as a source of Noggin in the
developing eye is exempliﬁed by (1) their expression of this BMP
inhibitor in different ocular tissues, (2) the reduction in Noggin
producing MyoD+/G8+ cells in the eyes following ablation in the
epiblast, (3) the disruption of eye morphogenesis in ablated embryos,
and (4) the ability of exogenous Noggin to fully or partially
compensate for the missing MyoD+ cells. Noggin producing
MyoD+ cells appear to affect eye development after the initial
speciﬁcation of ocular tissues since the Noggin soaked beads were
implanted into embryos containing lens placodes and optic vesicles.The Noggin bead experiment also raises the possibility that spatial
restriction of Noggin's release within the eye ﬁeld is not critical for
early stages of morphogenesis. However, the response of cells to
Noggin may depend on where they lie within a gradient of BMPs and/
or whether subpopulations of cells within the eye are rendered more
sensitive to the effects of Noggin by expressing cell surface Noggin
receptors (Ashe and Briscoe, 2006; Paine-Saunders et al., 2002;
Simeoni and Gurdon, 2007).
The malformations that arise as a result of ablating MyoD+
epiblast cells provide clues as to the functions of these cells in
different ocular tissues. Some ablated embryos exhibited small lenses.
Since lens ﬁber cell differentiation is promoted by BMPs (Beebe et al.,
2004; Belecky-Adams et al., 2002; de Longh et al., 2001; Faber et al.,
2002), release of Noggin from MyoD+ cells may be important for
modulating the initiation of differentiation in the equatorial zone.
Noggin also may affect the maturation of lens ﬁber cells, as suggested
by the appearance of MyoD+ cells in the posterior lens. The folding of
the retina that occurs when MyoD+ cells are ablated in the epiblast
suggests that the release of Noggin from these cells modulates the
effects of BMPs on proliferation in the retina (Trousse et al., 2001). In
the embryo containing a small and distorted optic cup, pigmentation
was present throughout the tissue. This phenotype may reﬂect
inappropriate BMP signaling since inhibition of BMPs is required for
specifying the unpigmented neural retina (Muller et al., 2007).
BMP signaling also is required for the development of the ciliary
body and iris but must be repressed for the differentiation of the
extraocular muscles (Tzahor et al., 2003; von Scheven et al., 2006;
Zhao et al., 2002). These tissues develop after day 5 when most
embryos die as a result of eliminating MyoD+ cells in the epiblast.
Therefore, examination of the roles of MyoD+ cells in the develop-
ment of the ciliary body, iris and extraocular muscles will require
ablation of MyoD+ cells within speciﬁc ocular tissues that is expected
to extend the viability of the embryo. Targeted ablation of MyoD+
cells in speciﬁc ocular tissues also will enable us to distinguish their
autonomous effects within the lens, optic cup and periocular
mesenchyme from inductive interactions that occur between these
tissues.
A common feature of the ablation experiments is that malforma-
tions are more pronounced on the right than the left side of the
embryo, including the eyes (Gerhart et al., 2006; present study). One
explanation for this phenomenon is that MyoD+ cells arising on the
left side of the epiblast after the ablation procedure may be
preferentially integrated into the left eye and release Noggin to afford
partial protection from excessive BMP signaling. This hypothesis is
supported by the fact that more residual MyoD+ epiblast cells are
present in the left than the right eye after ablation at stage 2. However,
the right eye may be more vulnerable to a reduction in MyoD+ cells
than the left eye because there are fewer of these cells in the right
lenses, and in some of the retinas, in normal, unablated embryos.
Differences in the numbers of MyoD+ cells in the right and left eyes of
normal embryos also may reﬂect asymmetric integration of MyoD+
cells that arise at different times within the epiblast or their different
rates of proliferation.
The malformations that occur when MyoD+ cells are ablated in
the epiblast (eye, facial and body wall defects) partially overlap with
anomalies present in newborns with Axenfeld–Rieger (AR) syndrome
(Gerhart et al., 2006; Hjalt and Semina, 2005; Lines et al., 2002; Lu et
al., 1999; Shields et al., 1985). While mutations in the transcription
factors PITX2, FOXC1, MAF and PAX6 are associated with AR and
related syndromes in humans and mice, the causes of these disorders
in many patients are unknown (Diehl et al., 2006; Gage et al., 1999;
Gould et al., 2004; Graw, 2003; Hjalt and Semina, 2005; Kitamura et
al., 1999; Lines et al., 2002). Abnormal behavior of neural crest cells
results in the development of AR syndrome in mice (Evans and Gage,
2005; Gage et al., 2005; Kupfer and Kaiser-Kupfer, 1978). Both the
neural crest and MyoD+ cells produce BMP inhibitors in the
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number of Noggin+/MyoD− cells that we detect in ocular tissues
may be derived from the neural crest. While neither MyoD+ cells nor
neural crest cells can completely compensate for the loss of the other
to prevent eye defects, the release of BMP inhibitors from the two cell
types may overlap to regulate eye development and the expression of
genes affected in ocular dysgenesis syndromes. In this regard, BMPs
indirectly inhibit Pitx2 expression during the establishment of
asymmetry in the body axis (Patel et al., 1999; Piedra and Ros,
2002; Schlange et al., 2001).
Our analyses of the developing embryo suggest that MyoD+
epiblast cells constitute a unique and stable lineagewhich functions to
deliver Noggin to skeletal muscle and non-skeletal muscle forming
tissues (Gerhart et al., 2006, 2007; present study). MyoD mRNA or
protein has been detected in multiple fetal and adult organs lacking
skeletal muscle (Chen et al., 2005; Gerhart et al., 2001; Grounds et al.,
1992). In addition to playing crucial roles during skeletal myogenesis
and eye development, cells that express MyoD mRNA and Noggin are
likely to regulate the behavior of neighboring stem and progenitor
cells in other tissues of the embryo and in the adult.
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